Search Results
Mar 18, 2026, 07:00 ET GentiBio Announces First Participant Dosed in POLARIS Phase 1 Clinical Trial of GNTI-122 in Recently Diagnosed Type 1 Diabetes
GentiBio on track to present key data in latter part of 2026 and 1H 2027 CAMBRIDGE, Mass., March 18, 2026 /PRNewswire/ -- GentiBio, Inc., a clinical-stage biotechnology company pioneering engineered,
More news about: GentiBio, Inc.
Mar 18, 2026, 07:00 ET Insurify Projects Average Home Insurance Price Will Climb 4% in 2026, After Jumping 12% in 2025
Since 2021, home insurance rates have soared 46%, nearly three times the rate of inflation.CAMBRIDGE, Mass., March 18, 2026 /PRNewswire/ -- Insurify, America's top-rated online insurance marketplace and leader in data-driven
More news about: INSURIFY, Inc.
Mar 18, 2026, 07:00 ET AT&T Launches New App to Simplify Customers' Digital Experience
built our new app around what customers told us they wanted most: simplicity, speed, and control," said Jenifer Robertson, AT&T's EVP and GM for Mass Markets. "This launch is an important step in enhancing seamless experiences, making every interaction easier and more intuitive so customers can
More news about: AT&T
Mar 18, 2026, 06:39 ET Guardian Angel Senior Services Promotes Three to Leadership Positions
BILLERICA, Mass., March 18, 2026 /PRNewswire/ -- Guardian Angel Senior Services, a privately owned senior home care company, recently announced the promotion of three of its staff members during the company's annual meeting.
More news about: Guardian Angel Senior Services
Mar 18, 2026, 06:00 ET Waters Prices Offering of Senior Notes
MILFORD, Mass., March 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) (the "Company" or "Waters") today announced that it has priced an offering (the "Offering") of $3.5 billion aggregate principal amount of the following
More news about: Waters Corporation
Mar 18, 2026, 04:30 ET Atrogi announces first subjects dosed in human trial for lead candidate ATR-258
health. Its lead candidate, ATR-258, is a first-in-class oral GRK2-biased β2-agonist designed to safely stimulate muscle metabolism and preserve lean mass, offering a novel approach to treating diabetes, obesity, and muscle loss.Atrogi's proprietary compound library, developed under the scientific
More news about: Atrogi AB
Mar 17, 2026, 20:54 ET Innorna anuncia la aprobación de la FDA de IND para IN026
gracias a la plataforma patentada de ARNm-LNP de Innorna.HONG KONG SAR, China y SHENZHEN, China y CAMBRIDGE, Mass., 18 de marzo de 2026 /PRNewswire/ -- Innorna, una empresa de biotecnología en fase clínica que desarrolla medicamentos
More news about: Innorna Co., Ltd.
Mar 17, 2026, 19:09 ET MediaTek Develops Active Optical Cable Technology with Microsoft Research to Deliver Significant Improvements in Data Center Efficiency
Cable can scale to 800 Gbps and beyond within standard QSFP/OSFP form factors. The two parties continue to explore opportunities in miniaturization and mass production readiness to advance the future development of gigawatt-scale AI data centers.For more information about this new technology, please
More news about: MediaTek Inc.
Mar 17, 2026, 17:15 ET Nuvalent to Present New Preclinical and Clinical Data for Zidesamtinib, an Investigational ROS1-Selective Inhibitor, at AACR Annual Meeting 2026
CAMBRIDGE, Mass., March 17, 2026 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely
More news about: Nuvalent, Inc.
Mar 17, 2026, 17:00 ET GV20 Therapeutics Announces Late-Breaking Oral Presentation of GV20-0251 Translational Findings at the AACR Annual Meeting 2026
NEWTON, Mass., March 17, 2026 /PRNewswire/ -- GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, today announced that it has been selected to deliver a late-breaking oral presentation highlighting
More news about: GV20 Therapeutics
Mar 17, 2026, 16:30 ET Immunitas Therapeutics to Present Clinical Data Supporting Monotherapy and Combination Treatment Potential of IMT-009 at the AACR 2026 Annual Meeting
WALTHAM, Mass., March 17, 2026 /PRNewswire/ --
More news about: Immunitas Therapeutics, Inc.
Mar 17, 2026, 15:38 ET BrioHealth Celebrates 100th BrioVAD® System Implant Milestone
Innovative Investigational Ventricular Assist Device Marks Major Step Forward in Patient CareBURLINGTON, Mass., March 17, 2026 /PRNewswire/ -- BrioHealth Solutions (
More news about: BrioHealth Solutions, Inc.
Mar 17, 2026, 15:12 ET Herzog Advances Rail Communications Webex Migration with C1
complex rail infrastructure construction to operations and maintenance for 17 transit properties. Herzog is consistently recognized among the Top 10 Mass Transit and Rail Contractors by Engineering News-Record.About C1C1 designs and delivers technology solutions engineered for outcomes.
More news about: C1
Mar 17, 2026, 12:00 ET FICG to Showcase Optical Technologies at OFC 2026, Expanding Global Presence
technologies such as Silicon Photonics, Co-Packaged Optics (CPO), and Optical Circuit Switching (OCS).FICG's 1.6T optical modules have entered mass production and are gradually achieving stable shipments, targeting large-scale data center deployments and the rapidly expanding CSP data center interconnect
More news about: FIC Global, Inc.
Mar 17, 2026, 12:00 ET Linux Foundation Announces $12.5 Million in Grant Funding from Leading Organizations to Advance Open Source Security
The Linux Foundation, the nonprofit organization enabling mass innovation through open source, today announced $12.5 million in total grants from
More news about: The Linux Foundation
Mar 17, 2026, 11:45 ET PHOENIX IS WORST AMONG AMERICA'S BIG CITIES FOR SEPARATING CHILDREN FROM THEIR FAMILIES, NATIONAL COALITION FOR CHILD PROTECTION REFORM SAYS
mass of research showing that, in typical cases, not the horror stories, children left in their own homes typically fare better even than comparably-maltreated
More news about: National Coalition for Child Protection Reform
Mar 17, 2026, 11:04 ET Law Offices of James Scott Farrin Adopt Eve to Build an AI-Native Law Firm and Scale High-Quality Legal Representation
Led by President James Farrin, the firm represents thousands of clients across personal injury, workers' compensation, Social Security disability, mass torts, and eminent domain. As case volumes and complexity have increased, the firm made a deliberate decision to move beyond treating technology as
More news about: Eve
Mar 17, 2026, 11:00 ET OCHIN and C3 combine strengths to launch new Medicare ACO
growing patient demand in rural and community care settingsPORTLAND, Ore. and BOSTON, Mass., March 17, 2026 /PRNewswire/ --
More news about: OCHIN
Mar 17, 2026, 10:55 ET Korean Skincare Brand JiYu Raises $6.5M to Expand U.S. Market, Tracking Toward $70M Revenue in 2026
SCIENCEJiYu's flagship Renewal & Rejuvenation Toner Pads represent one of the most comprehensive multi-action toner formulas to reach the mass market. At the heart of the formula is K8-Rejuvenate™, JiYu's trademarked proprietary blend — a precision-crafted complex of Snail Mucin, Centella
More news about: JiYu
Mar 17, 2026, 10:41 ET Advancing Autonomy: Applied Intuition Collaborates with NVIDIA to Accelerate Adoption of Autonomous Driving Technology
with autonomy software and tooling optimized to work together from the start."Advanced driver assistance is becoming a baseline expectation for mass-market vehicles," said Varun Mittal, president of Applied Intuition. "Our work with NVIDIA raises the bar across the full range of powertrains—from
More news about: Applied Intuition, Inc.
Mar 17, 2026, 10:17 ET DeepRoute.ai Presents 40B Vision-Language-Action Foundation Model at NVIDIA GTC 2026, Accelerating Autonomous Driving at Scale
Scale and Momentum: 250K to 1M Vehicles"By the end of 2025, we successfully delivered over 250,000 mass-produced vehicles equipped with DeepRoute.ai's autonomous driving systems," Cao said. "The Foundation Model serves as the core cornerstone for DeepRoute.ai's
More news about: DeepRoute.ai
Mar 17, 2026, 10:17 ET Trevor Paglen Selected as the 2026 LG Guggenheim Award Recipient
underlying architectures that shape our modes of perception.Looking beyond art and culture alone, Paglen examines the power structures surrounding mass technologies and the exchanges they facilitate––between cultural myths, national narratives, and deeply embedded social assumptions. His engagement
More news about: LG Corp.
Mar 17, 2026, 10:15 ET UNIBIRD Launches N200M Visual Navigation Module for GPS-Denied Environments
DUBAI, UAE, March 17, 2026 /PRNewswire/ -- Following the successful launch of the world's first mass-produced N200 VIO navigation module at a price of USD 399, UNIBIRD has officially introduced its upgraded solution—the N200M Visual Navigation Module
More news about: UNIBIRD
Mar 17, 2026, 10:15 ET Personal Care and Cosmetics Microalgae Market to Reach USD 117 Million by 2035, Driven by Clean Beauty, Biotech Innovation, and Sustainable Skincare Demand
actively shifting toward vegan, cruelty-free, and organic beauty solutions, positioning microalgae as a high-value ingredient in both premium and mass-market formulations.Clean Beauty Movement Accelerates Market ExpansionThe global clean beauty movement continues to reshape product
More news about: Future Market Insights
Mar 17, 2026, 10:11 ET University of Nebraska's NSRI awarded $500 million contract to accelerate warfighter-ready solutions
established in 2012, NSRI has delivered leading academic research and critical tools across two DOW missions — strategic deterrence and countering weapons of mass destruction. Its
More news about: National Strategic Research Institute